These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 20186024)

  • 21. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New TNM classification for non-small-cell lung cancer.
    Tanoue LT; Detterbeck FC
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):413-23. PubMed ID: 19374596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H
    Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Spanish Society of Pulmonology and Thoracic Surgery Lung Cancer Cooperative Group-II registry. A descriptive study.
    Sánchez de Cos Escuín J; Serra Mitjans M; Hernández Hernández J; Hernández Rodríguez H; Abal Arca J; Parente Lamelas I; León Atance P; Núñez Ares A; Miravet Sorribes L; Blanco Orozco AI; Melchor ĺñiguez R; García Arangüena L; Arnau Obrer A; Guijarro Jorge R; Padilla Alarcón J; Peñalver Cuesta JC; Mariñán Gorospe M; Fernández Araujo E; Francisco Corral G; Cerezo González S; González Casaurrán G; Naranjo Gozalo S; Álvarez de Arriba C; Núñez Delgado M; González Budiño MT; Magaroles R; de Esteban Júlvez L; Pavón Fernández MJ; Gullón Blanco JA; de Olaiz Navarro B; Escobar Campuzano I; Macía Vidueira I; García Barajas S; Herrero Collantes J; Freixenet Gilabert J; Saura Vinuesa A
    Arch Bronconeumol; 2013 Nov; 49(11):462-7. PubMed ID: 23838409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of tumor size eliminating the ground glass opacity component: modified clinical T descriptors of the tumor, node, metastasis classification of lung cancer.
    Nakamura S; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ishiguro F; Hirakawa A; Yokoi K
    J Thorac Oncol; 2013 Dec; 8(12):1551-7. PubMed ID: 24389437
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of a surgical specimen-collection kit to improve mediastinal lymph-node examination of resectable lung cancer.
    Osarogiagbon RU; Miller LE; Ramirez RA; Wang CG; O'Brien TF; Yu X; Khandekar A; Schoettle GP; Robbins SG; Robbins ET; Gibson JB
    J Thorac Oncol; 2012 Aug; 7(8):1276-82. PubMed ID: 22653076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database.
    Yoshida J; Nagai K; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Aug; 4(8):959-63. PubMed ID: 19458555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs.
    Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H
    J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The revised TNM staging system for lung cancer.
    Rami-Porta R; Crowley JJ; Goldstraw P
    Ann Thorac Cardiovasc Surg; 2009 Feb; 15(1):4-9. PubMed ID: 19262443
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
    Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
    J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
    Ou SH; Zell JA
    J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.
    Higgins KA; Chino JP; Ready N; D'Amico TA; Berry MF; Sporn T; Boyd J; Kelsey CR
    J Thorac Oncol; 2012 Jul; 7(7):1141-7. PubMed ID: 22617241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002.
    Sawabata N; Asamura H; Goya T; Mori M; Nakanishi Y; Eguchi K; Koshiishi Y; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Sep; 5(9):1369-75. PubMed ID: 20683209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging of non-small cell lung cancer (NSCLC): a review.
    Tsim S; O'Dowd CA; Milroy R; Davidson S
    Respir Med; 2010 Dec; 104(12):1767-74. PubMed ID: 20833010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer.
    Rami-Porta R; Bolejack V; Giroux DJ; Chansky K; Crowley J; Asamura H; Goldstraw P;
    J Thorac Oncol; 2014 Nov; 9(11):1618-24. PubMed ID: 25436796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
    Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of reclassification from the TNM-6 into the TNM-7 staging system in bronchoplastic resection for non-small cell lung cancer.
    Klikovits T; End A; Riedl G; Stiebler M; Dekan G; Klepetko W
    Interact Cardiovasc Thorac Surg; 2011 Jul; 13(1):29-34. PubMed ID: 21525027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of the 2007 lung cancer staging system by International Association for the Study of Lung Cancer].
    Wang J; Wu N; Zheng QF; Feng Y; Yan S; Yang Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 41(4):442-6. PubMed ID: 19727235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
    Ignatius Ou SH; Zell JA
    J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the 6th and 7th editions of the American Joint Committee on Cancer tumor-node-metastasis staging system in patients with resected esophageal carcinoma.
    Hsu PK; Wu YC; Chou TY; Huang CS; Hsu WH
    Ann Thorac Surg; 2010 Apr; 89(4):1024-31. PubMed ID: 20338302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.